
X
Roche’s Herceptin/Perjeta combo product nears EU approval
https://pharmaphorum.com/news/roches-herceptin-perjeta-combo-product-nears-eu-approval/
Ontruzant, the first biosimilar version of Roche’s Herceptin (trastuzumab) in Europe has been launched in the UK by MSD.
South Korean firm trying to copy breast cancer blockbuster.